Temporal validation of the MMCD score to predict kidney replacement therapy and in-hospital mortality in COVID-19 patients.
Vanessa das Graças José VenturaPolianna Delfino PereiraMagda Carvalho PiresAlisson Alves AsevedoAlzira de Oliveira JorgeAna Carolina Pitanga Dos SantosAndré Soares de Moura CostaAngélica Gomides Dos Reis GomesBeatriz Figueiredo LimaBruno Porto PessoaChristiane Correa Rodrigues CiminiClaudio Moisés Valiense de AndradeDaniela PonceDanyelle Romana Alves RiosElayne Crestani PereiraEuler Roberto Fernandes ManentiEvelin Paola de Almeida CenciFelício Roberto CostaFernando AnschauFernando Graça AranhaFlavia Maria Borges VigilFrederico BartolazziGabriella Genta AguiarGenna Maira Santos GrizendeJoanna d'Arc Lyra BatistaJoão Victor Baroni NevesKaren Brasil RuschelLetícia do NascimentoLucas Moyses Carvalho de OliveiraLuciane KopittkeLuís César de CastroManuela Furtado SaciotoMarcelo CarneiroMarcos André GonçalvesMaria Aparecida Camargos BicalhoMônica Aparecida de Paula de SordiNatália da Cunha Severino SampaioPedro Gibson ParaisoRochele Mosmann MenezesSilvia Ferreira AraújoVivian Costa Morais de AssisKátia de Paula FarahMilena Soriano MarcolinoPublished in: BMC nephrology (2023)
The MMCD score is not appropriate for in-hospital mortality but demonstrates an excellent predictive ability to predict KRT in COVID-19 patients. The instrument is low cost, objective, fast and accurate, and can contribute to supporting clinical decisions in the efficient allocation of assistance resources in patients with COVID-19.